Cough Reduction in IPF With Nalbuphine ER

Clinical trial NCT05964335 · COMPLETED

Trial details

NCT number: NCT05964335
Sponsor: Trevi Therapeutics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Idiopathic Pulmonary Fibrosis

Start date: 2024-02-06
Primary completion: 2025-04-24
Enrollment: 165

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.